The Department of Veterans Affairs stopped distributing the drug Prazosin, which helps stop PTSD nightmares, after an FDA ...
Ananda Scientific Inc., a clinical-stage drug development company advancing innovative therapies for high-impact ...
A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to win a ...
The Scottsdale Research Institute (SRI) is preparing to begin a landmark study on the use of whole psilocybin mushrooms to ...
About 12 million adults in the United States are affected by PTSD, impacting between 4% and 8% of the adult population – and up to 30% of military personnel and veterans. Strikingly, 63% of veterans ...
Ananda Scientific Inc., a clinical-stage drug development company, and Benta SAS have signed a Memorandum of Understanding (MOU).
Researchers are discovering that post-traumatic stress disorder (PTSD) is a significant risk factor in developing dementia. Dementia is a memory problem that affects a person's ability to carry out ...
The VA is expanding psychedelic-assisted therapy trials for PTSD and depression at nine facilities, exploring new hope for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results